Skip to content

REAN: what changed

BE 0788.547.642NACE 47.730, Retail sale of pharmaceutical productsOther company

Position among the sector peers

What moved between 2024 and 2025

Net result for the year
€20,491
2024 · €31,035-€10,544
Equity
€48,365
2024 · €79,575-€31,209
Cash
€28,169
2024 · €59,777-€31,607
Balance sheet total
€60,193
2024 · €91,347-€31,154

Largest movements

2024 to 2025
Assets
  • Cash -€31,607

    down €31,607 (-52.9%), from €59,777 to €28,169

    mainly Contributions, distributions and other (-€51,700) and Investment in fixed assets (net) (-€6,222)

  • Tangible fixed assets +€1,399

    up €1,399 (+7.0%), from €19,972 to €21,372

    of which Other tangible fixed assets: +€4,715

  • Receivables within one year -€951

    down €951 (-8.4%), from €11,332 to €10,381

    of which Other amounts receivable: -€869

Equity and liabilities
  • Reserves -€31,209

    down €31,209 (-42.4%), from €73,575 to €42,365

  • Other debts +€1,700

    new in 2025: €1,700

  • Trade debts -€1,325

    down €1,325 (-33.0%), from €4,019 to €2,694

Income statement
  • Gross operating margin -€8,334

    down €8,334 (-18.5%), from €45,011 to €36,677

  • Depreciation +€1,505

    up €1,505 (+45.4%), from €3,317 to €4,822

  • Taxes +€713

    up €713 (+7.3%), from €9,796 to €10,509

Change in the result, 2024 to 2025

effect on the result

For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.

Result 2024 €31,035
Gross operating margin -€8,334
Depreciation -€1,505
Other operating charges -€2
Financial income +€6
Financial charges +€5
Taxes -€713
Result 2025 €20,491
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.

From operations +€26,314
Investment -€6,222
Financing -€51,700
Cash 2024 €59,777
Net result for the year +€20,491
Depreciation +€4,822
Receivables within one year +€951
Deferred charges and accrued income -€6
Trade debts -€1,325
Tax, wage and social debts -€319
Other debts +€1,700
Investment in fixed assets (net) -€6,222
Contributions, distributions and other -€51,700
Cash 2025 €28,169
brings cash intakes cash out
Every line side by side 35 lines
Line Code 2024 2025 Change %
Total assets 20/58 €91,347 €60,193 -€31,154 -34.1%
Fixed assets 21/28 €19,972 €21,372 +€1,399 +7.0%
Tangible fixed assets 22/27 €19,972 €21,372 +€1,399 +7.0%
Furniture and vehicles 24 €16,372 €13,057 -€3,316 -20.3%
Other tangible fixed assets 26 €3,600 €8,315 +€4,715 +131%
Current assets 29/58 €71,374 €38,821 -€32,553 -45.6%
Amounts receivable within one year 40/41 €11,332 €10,381 -€951 -8.4%
Trade receivables 40 €8,340 €8,258 -€82 -1.0%
Other amounts receivable 41 €2,992 €2,123 -€869 -29.1%
Cash at bank and in hand 54/58 €59,777 €28,169 -€31,607 -52.9%
Deferred charges and accrued income 490/1 €265 €271 +€6 +2.1%
Total equity and liabilities 10/49 €91,347 €60,193 -€31,154 -34.1%
Equity 10/15 €79,575 €48,365 -€31,209 -39.2%
Contributions 10/11 €6,000 €6,000 = 0.0%
Reserves 13 €73,575 €42,365 -€31,209 -42.4%
Distributable reserves 133 €73,575 €42,365 -€31,209 -42.4%
Amounts payable 17/49 €11,772 €11,828 +€56 +0.5%
Amounts payable within one year 42/48 €11,772 €11,828 +€56 +0.5%
Trade debts 44 €4,019 €2,694 -€1,325 -33.0%
Suppliers 440/4 €4,019 €2,694 -€1,325 -33.0%
Taxes, remuneration and social security 45 €7,753 €7,434 -€319 -4.1%
Taxes 450/3 €7,753 €7,434 -€319 -4.1%
Other amounts payable 47/48 - €1,700 +€1,700
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €3,317 €4,822 +€1,505 +45.4%
Other operating charges 640/8 €947 €949 +€2 +0.2%
Gross operating margin 9900 €45,011 €36,677 -€8,334 -18.5%
Operating profit (loss) 9901 €40,747 €30,906 -€9,841 -24.2%
Financial income 75/76B €166 €172 +€6 +3.4%
Recurring financial income 75 €166 €172 +€6 +3.4%
Financial charges 65/66B €83 €78 -€5 -5.6%
Recurring financial charges 65 €83 €78 -€5 -5.6%
Profit (loss) for the period before taxes 9903 €40,831 €31,000 -€9,831 -24.1%
Income taxes 67/77 €9,796 €10,509 +€713 +7.3%
Profit (loss) for the period 9904 €31,035 €20,491 -€10,544 -34.0%
Profit (loss) for the period to be appropriated 9905 €31,035 €20,491 -€10,544 -34.0%

Value

latest balance sheet 31-12-2025 · indication, not a valuation or advice

Indicative value of the equity

Indication, not a valuation or advice
€128,351 to €170,018

Midpoint €145,712 · 50% capitalised earnings, 50% adjusted equity

Capitalisation rate 12% result over 3 years earnings weight 50%

Adjusted equity €48,365
Capitalised earnings €208,336 to €291,670
Indication €128,351 to €170,018

Adjusted equity

balance sheet 31-12-2025
Equity (10/15)
€48,365
Revaluation of assets
€0
Deferred tax on the revaluation
€0
Other adjustment
€0
Adjusted equity
€48,365

Capitalised earnings

net result for the year (9904)
2025
€20,491
2024
€31,035
2023
€35,976
2022
€6,564
Average result
€29,167
Divided by the capitalisation rate
14% / 12% / 10%
Capitalised earnings
€208,336 / €243,058 / €291,670

Limits of the indication

  • Checked holds no market prices or comparable transactions.
  • Anything after the latest accounts and items off the balance sheet (guarantees, leases, disputes) are left out.
  • Checked does not know the real value of buildings, stock and receivables. Enter your own revaluation or adjustment for it.
  • The owner's role in the business, synergies for a buyer and the tax consequences of a sale are left out.

For a valuation to base a decision on, go to a company auditor or a certified accountant.

Calculation and sources

Source: filed annual accounts (NBB) and main activity (KBO). The movements compare the financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. The value is an indication, not a valuation or advice. Prepared on 8 November 2026 via checked.be.